Skip to content

BBNX BBNX Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$132.97M-7.5%
AdaptHealth logo
AdaptHealthAHCO
$127.56M+23.2%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$32.42M+10.3%

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's operating lease liabilities (total)?
BBNX (BBNX) reported operating lease liabilities (total) of $6.91M in Q1 2026.
How has BBNX's operating lease liabilities (total) changed year-over-year?
BBNX's operating lease liabilities (total) decreased by 0.9% year-over-year, from $6.97M to $6.91M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.